{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T17:51:14Z","timestamp":1789926674969,"version":"4.0.1"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2015,12,21]],"date-time":"2015-12-21T00:00:00Z","timestamp":1450656000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0145404","type":"journal-article","created":{"date-parts":[[2015,12,21]],"date-time":"2015-12-21T18:48:02Z","timestamp":1450723682000},"page":"e0145404","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":53,"title":["Inflammasome Modulation by Chemotherapeutics in Malignant Mesothelioma"],"prefix":"10.1371","volume":"10","author":[{"given":"Catherine","family":"Westbom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce K.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Leggett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"MacPherson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacie","family":"Beuschel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvey","family":"Pass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Vacek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arti","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,12,21]]},"reference":[{"issue":"4","key":"ref1","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s11912-002-0006-2","article-title":"Current therapy for malignant mesothelioma","volume":"4","author":"WR Smythe","year":"2002","journal-title":"Current oncology reports"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1749-6632.2010.05554.x","article-title":"Inflammation precedes the development of human malignant mesotheliomas in a SCID mouse xenograft model","volume":"1203","author":"JM Hillegass","year":"2010","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"10","key":"ref3","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1016\/j.ajpath.2014.06.008","article-title":"CREB-induced inflammation is important for malignant mesothelioma growth","volume":"184","author":"CM Westbom","year":"2014","journal-title":"The American journal of pathology"},{"issue":"6","key":"ref4","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.coi.2007.09.002","article-title":"The inflammasome: a danger sensing complex triggering innate immunity","volume":"19","author":"V Petrilli","year":"2007","journal-title":"Current opinion in immunology"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1158\/0008-5472.CAN-06-2956","article-title":"Interleukin-1beta-driven inflammation promotes the development and invasiveness of chemical carcinogen-induced tumors","volume":"67","author":"Y Krelin","year":"2007","journal-title":"Cancer research"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4137\/BIC.S25375","article-title":"Interleukin 1beta-A Potential Salivary Biomarker for Cancer Progression?","volume":"7","author":"A Idris","year":"2015","journal-title":"Biomarkers in cancer"},{"issue":"1","key":"ref7","first-page":"173","article-title":"Interleukin-1beta and tumour necrosis factor-alpha promote the transformation of human immortalised mesothelial cells by erionite","volume":"25","author":"Y Wang","year":"2004","journal-title":"International journal of oncology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1743-8977-10-39","article-title":"Asbestos and erionite prime and activate the NLRP3 inflammasome that stimulates autocrine cytokine release in human mesothelial cells","volume":"10","author":"JM Hillegass","year":"2013","journal-title":"Particle and fibre toxicology"},{"issue":"23","key":"ref9","doi-asserted-by":"crossref","first-page":"13249","DOI":"10.1073\/pnas.231473998","article-title":"IL-1 beta -converting enzyme (caspase-1) in intestinal inflammation","volume":"98","author":"B Siegmund","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"9","key":"ref10","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1136\/gut.2009.197822","article-title":"Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome","volume":"59","author":"C Bauer","year":"2010","journal-title":"Gut"},{"issue":"5","key":"ref11","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1084\/jem.20100050","article-title":"The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer","volume":"207","author":"IC Allen","year":"2010","journal-title":"The Journal of experimental medicine"},{"issue":"5","key":"ref12","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.ccr.2011.10.022","article-title":"The NOD-like receptor NLRP12 attenuates colon inflammation and tumorigenesis","volume":"20","author":"MH Zaki","year":"2011","journal-title":"Cancer cell"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1128\/MCB.20.4.1436-1447.2000","article-title":"Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics","volume":"20","author":"MA Dickson","year":"2000","journal-title":"Molecular and cellular biology"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0003-4975(95)00045-M","article-title":"Characteristics of nine newly derived mesothelioma cell lines","volume":"59","author":"HI Pass","year":"1995","journal-title":"The Annals of thoracic surgery"},{"issue":"12","key":"ref15","first-page":"3199","article-title":"Characterization of a human malignant mesothelioma cell line (H-MESO-1): a biphasic solid and ascitic tumor model","volume":"47","author":"FR Reale","year":"1987","journal-title":"Cancer research"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/1476-4598-9-314","article-title":"Blocking of ERK1 and ERK2 sensitizes human mesothelioma cells to doxorubicin","volume":"9","author":"A Shukla","year":"2010","journal-title":"Molecular cancer"},{"issue":"8","key":"ref17","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1158\/1078-0432.CCR-12-3202","article-title":"Extracellular signal-regulated kinase 5: a potential therapeutic target for malignant mesotheliomas","volume":"19","author":"A Shukla","year":"2013","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"issue":"6","key":"ref18","doi-asserted-by":"crossref","first-page":"e39404","DOI":"10.1371\/journal.pone.0039404","article-title":"Peroxiredoxin 3 is a redox-dependent target of thiostrepton in malignant mesothelioma cells","volume":"7","author":"K Newick","year":"2012","journal-title":"PloS one"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/ijc.25666","article-title":"Increased efficacy of doxorubicin delivered in multifunctional microparticles for mesothelioma therapy","volume":"129","author":"JM Hillegass","year":"2011","journal-title":"International journal of cancer Journal international du cancer"},{"issue":"4","key":"ref20","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1681\/ASN.V134858","article-title":"Cisplatin induces apoptosis in LLC-PK1 cells via activation of mitochondrial pathways. Journal of the American Society of Nephrology","volume":"13","author":"MS Park","year":"2002","journal-title":"JASN"},{"issue":"7","key":"ref21","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1096\/fj.05-4554fje","article-title":"Transcriptional up-regulation of MMP12 and MMP13 by asbestos occurs via a PKCdelta-dependent pathway in murine lung","volume":"20","author":"A Shukla","year":"2006","journal-title":"Faseb J"},{"issue":"7","key":"ref22","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1096\/fj.05-4554fje","article-title":"Transcriptional up-regulation of MMP12 and MMP13 by asbestos occurs via a PKCdelta-dependent pathway in murine lung","volume":"20","author":"A Shukla","year":"2006","journal-title":"FASEB journal: official publication of the Federation of American Societies for Experimental Biology"},{"issue":"5","key":"ref23","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/ijc.25763","article-title":"ERK2 is essential for the growth of human epithelioid malignant mesotheliomas","volume":"129","author":"A Shukla","year":"2011","journal-title":"International journal of cancer Journal international du cancer"},{"issue":"5","key":"ref24","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.2353\/ajpath.2009.090400","article-title":"Activated cAMP response element binding protein is overexpressed in human mesotheliomas and inhibits apoptosis","volume":"175","author":"A Shukla","year":"2009","journal-title":"The American journal of pathology"},{"issue":"2","key":"ref25","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/jcp.21770","article-title":"IL-1beta receptor blockade protects islets against pro-inflammatory cytokine induced necrosis and apoptosis","volume":"220","author":"A Schwarznau","year":"2009","journal-title":"Journal of cellular physiology"},{"issue":"8","key":"ref26","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nrd3800","article-title":"Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases","volume":"11","author":"CA Dinarello","year":"2012","journal-title":"Nature reviews Drug discovery"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/wnan.54","article-title":"Assessing nanotoxicity in cells in vitro","volume":"2","author":"JM Hillegass","year":"2010","journal-title":"Wiley interdisciplinary reviews Nanomedicine and nanobiotechnology"},{"issue":"33","key":"ref28","doi-asserted-by":"crossref","first-page":"20167","DOI":"10.1074\/jbc.M115.652321","article-title":"Caspase-8 as an Effector and Regulator of NLRP3 Inflammasome Signaling","volume":"290","author":"C Antonopoulos","year":"2015","journal-title":"The Journal of biological chemistry"},{"key":"ref29","article-title":"The interleukin (IL)-1 cytokine family\u2014Balance between agonists and antagonists in inflammatory diseases","author":"J Palomo","year":"2015","journal-title":"Cytokine"},{"issue":"12","key":"ref30","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1074\/mcp.M800132-MCP200","article-title":"Targeted peptidecentric proteomics reveals caspase-7 as a substrate of the caspase-1 inflammasomes","volume":"7","author":"M Lamkanfi","year":"2008","journal-title":"Molecular & cellular proteomics: MCP"},{"issue":"3","key":"ref31","first-page":"1227","article-title":"Loss of caspase-1 and caspase-3 protein expression in human prostate cancer","volume":"61","author":"RN Winter","year":"2001","journal-title":"Cancer research"},{"issue":"3a","key":"ref32","first-page":"1377","article-title":"Caspase-1 enhances the apoptotic response of prostate cancer cells to ionizing radiation","volume":"24","author":"RN Winter","year":"2004","journal-title":"Anticancer research"},{"issue":"12","key":"ref33","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.it.2014.10.004","article-title":"Caspase crosstalk: integration of apoptotic and innate immune signalling pathways","volume":"35","author":"EM Creagh","year":"2014","journal-title":"Trends in immunology"},{"issue":"9","key":"ref34","doi-asserted-by":"crossref","first-page":"4789","DOI":"10.4049\/jimmunol.1300645","article-title":"Proapoptotic chemotherapeutic drugs induce noncanonical processing and release of IL-1beta via caspase-8 in dendritic cells","volume":"191","author":"C Antonopoulos","year":"2013","journal-title":"J Immunol"},{"issue":"1","key":"ref35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nm.2999","article-title":"Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth","volume":"19","author":"M Bruchard","year":"2013","journal-title":"Nature medicine"},{"key":"ref36","first-page":"1","article-title":"A pan caspase inhibitor decreases caspase-1, IL-1alpha and IL-1beta, and protects against necrosis of cisplatin-treated freshly isolated proximal tubules","volume":"2014","author":"DW Lee","year":"2014","journal-title":"Renal failure"},{"key":"ref37","article-title":"P2X7 receptor blockade protects against cisplatin-induced nephrotoxicity in mice by decreasing the activities of inflammasome components, oxidative stress and caspase-3","author":"Y Zhang","year":"2014","journal-title":"Toxicology and applied pharmacology"},{"issue":"10","key":"ref38","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.4161\/cbt.29922","article-title":"Production of IL-1beta by bone marrow-derived macrophages in response to chemotherapeutic drugs: synergistic effects of doxorubicin and vincristine","volume":"15","author":"J Wong","year":"2014","journal-title":"Cancer biology & therapy"},{"issue":"6","key":"ref39","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1684\/bdc.2014.1936","article-title":"Impact of chemotherapies on immunosuppression and discovery of new therapeutic targets","volume":"101","author":"M Bruchard","year":"2014","journal-title":"Bulletin du cancer"},{"issue":"1","key":"ref40","doi-asserted-by":"crossref","first-page":"e27499","DOI":"10.4161\/onci.27499","article-title":"Chemotherapy engages multiple pathways leading to IL-1beta production by myeloid leukocytes","volume":"3","author":"C Antonopoulos","year":"2014","journal-title":"Oncoimmunology"},{"issue":"1","key":"ref41","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1158\/0008-5472.CAN-11-2001","article-title":"HMGB1 promotes drug resistance in osteosarcoma","volume":"72","author":"J Huang","year":"2012","journal-title":"Cancer research"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/1476-4598-13-165","article-title":"HMGB1-mediated autophagy promotes docetaxel resistance in human lung adenocarcinoma","volume":"13","author":"B Pan","year":"2014","journal-title":"Molecular cancer"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0145404","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T02:07:19Z","timestamp":1653876439000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0145404"}},"subtitle":[],"editor":[{"given":"Irving Coy","family":"Allen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,12,21]]},"references-count":42,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2015,12,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0145404","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,21]]}}}